Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000947871-23-000437
Filing Date
2023-04-07
Accepted
2023-04-07 16:38:32
Documents
2
Group Members
ORBIMED ADVISORS ISRAEL II LTDORBIMED CAPITAL GP VII LLCORBIMED CAPITAL LLCORBIMED GENESIS GP LLCORBIMED ISRAEL GP II, L.P.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 ss1953707_sc13da.htm SC 13D/A 175770
2 JOINT FILING AGREEMENT ss1953707_ex9901.htm EX-99.1 9639
  Complete submission text file 0000947871-23-000437.txt   187181
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

EIN.: 133976876 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address 75 STATE STREET SUITE 100 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 100 BOSTON MA 02109 45-70-70-52-10
Galecto, Inc. (Subject) CIK: 0001800315 (see all company filings)

EIN.: 371957007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91812 | Film No.: 23809068
SIC: 2834 Pharmaceutical Preparations